Hunter Perkins Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$5.83M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$4.38M |
| 3 |
TSMC
TSM
|
+$2.11M |
| 4 |
Prologis
PLD
|
+$1.95M |
| 5 |
Webster Financial
WBS
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$6.95M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.85M |
| 3 |
Polaris
PII
|
+$4.97M |
| 4 |
Graphic Packaging
GPK
|
+$4.15M |
| 5 |
Hartford Financial Services
HIG
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.9% |
| 2 | Healthcare | 17.65% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 11.16% |
| 5 | Real Estate | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
SPDR Gold Trust
GLD
$138B
| $202K | 0.05% |
+700
| New | +$185K |
|
102
Nuvation Bio
NUVB
$2.13B
| $40K | 0.01% |
22,500
| – | – |
|
103
AtaiBeckley Inc
ATAI
$2.66B
| $23K | 0.01% |
17,241
| – | – |
|
|
MRSN
104
DELISTED
Mersana Therapeutics
MRSN
| $3K | ﹤0.01% |
400
| – | – |
|
105
Arcos Dorados Holdings
ARCO
$1.76B
| – | – |
-40,000
| Closed | -$291K |
|
106
Lamar Advertising Co
LAMR
$16.2B
| – | – |
-7,925
| Closed | -$965K |
|
|
LAND
107
Gladstone Land Corp
LAND
$360M
| – | – |
-37,450
| Closed | -$406K |
|
|
NSA
108
DELISTED
National Storage Affiliates Trust
NSA
| – | – |
-8,650
| Closed | -$328K |
|
|
109
Polaris
PII
$3.99B
| – | – |
-86,249
| Closed | -$4.97M |
|
|
RMT
110
Royce Micro-Cap Trust
RMT
$751M
| – | – |
-13,093
| Closed | -$128K |
|
111
United Parcel Service
UPS
$87.7B
| – | – |
-27,485
| Closed | -$3.47M |
|
Similar funds
Hunter Perkins Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Hunter Perkins Capital Management held 111 positions worth $431M, down 9.6% from $476M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Hunter Perkins Capital Management withdrew a net $48.8M in Q1 2025, closing 7 positions and reducing 52 holdings. Its most notable exit was Polaris, an estimated $4.97M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Hunter Perkins Capital Management opened a new position in Regeneron Pharmaceuticals worth $5.38M.
- Hunter Perkins Capital Management's largest Q1 2025 buy was Regeneron Pharmaceuticals: 8,482 shares worth $5.38M.
- Hunter Perkins Capital Management added most to TSMC in Q1 2025, an estimated $2.11M increase.
- Hunter Perkins Capital Management's biggest Q1 2025 reduction was Johnson & Johnson, cutting an estimated $6.95M.
- Hunter Perkins Capital Management fully exited Polaris in Q1 2025, selling an estimated $4.97M.
- Hunter Perkins Capital Management's ten largest holdings make up 41% of its $431M portfolio in Q1 2025.
- Hunter Perkins Capital Management opened 7 new positions and closed 7 in Q1 2025.
- Hunter Perkins Capital Management's portfolio value fell 9.6% quarter-over-quarter to $431M.
Based on Hunter Perkins Capital Management's 13F filing for Q1 2025, filed 24 Apr 2025.